Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

The More Effective and the More (bio) Similar: Plerixafor and Filgrastim XM02 (tevagastrim) As First Line PBSC Mobilization Strategy in Patients with Multiple Myeloma and Lymphomas Candidate to ABMT

Daniele Laszlo, Giovanna Andreola, Aleksandra Babic, Mara Negri, Cristina Rabascio, Ambra Malerba, Monica Drera, Elezi Rufije, Giovanni Martinelli, MD

Blood (2011) 118 (21): 2994.

https://doi.org/10.1182/blood.V118.21.2994.2994

Published: 2011

Journal Articles

Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34 − cell population with intrinsic resistance to imatinib

Roberto M. Lemoli, Valentina Salvestrini, Elisa Bianchi, Francesco Bertolini, Miriam Fogli, Marilina Amabile, Agostino Tafuri, Simona Salati, Roberta Zini, Nicoletta Testoni, Cristina Rabascio, Lara Rossi, Ines Martin-Padura, Fausto Castagnetti, Paola Marighetti, Giovanni Martinelli, Michele Baccarani, Sergio Ferrari, Rossella Manfredini

Blood (2009) 114 (25): 5191–5200.

https://doi.org/10.1182/blood-2008-08-176016

Published: 2009

Includes: Supplemental data

Journal Articles

Rituximab Reduces Anti-UL94 and Anti-NAG-2 Antibodies Titer and Is Effective against Skin-Chronic Graft Versus Host Disease Resembling Scleroderma.

Rocco Pastano, Chiara Dell'Agnola, Caterina Bason, Federica Gigli, Cristina Rabascio, Antonio Puccetti, Gianluigi Cetto, Fedro Alessandro Peccatori, Giovanni Martinelli, Claudio Lunardi

Blood (2009) 114 (22): 4654.

https://doi.org/10.1182/blood.V114.22.4654.4654

Published: 2009

Journal Articles

90 y-Ibritumomab Tiuxetan or Purine Analogues Severely Affect Peripheral Blood Stem Cell Mobilization: An Analysis On 248 Patients.

Anna Vanazzi, MD, Alessandra Alietti, MD, Alberto Agazzi, MD, Mara Negri, Maria Teresa Lionetti, Aleksandra Babic, Davide Radice, Luca Nassi, MD, Simona Sammassimo, MD, Cristina Rabascio, Pierluigi Antoniotti, Lara Roveda, Bruno Lucchetti, Tiziana Suardi, Alessio Piredda, Liliana Calabrese, Giovanni Martinelli, MD, Daniele Laszlo, MD

Blood (2009) 114 (22): 3210.

https://doi.org/10.1182/blood.V114.22.3210.3210

Published: 2009

Journal Articles

Rituximab and Chlorambucil as Front-Line Treatment in Untreated Follicular Lymphoma: a Combination with a Durable Response and Low Toxicity Profile.

Simona Bassi, MD, Luca Nassi, MD, Giancarlo Pruneri, MD, Simona Sammassimo, MD, Paola Bertazzoni, MD, Federica Gigli, MD, Anna Vanazzi, MD, Emilia Cocorocchio, MD, Patrizia Mancuso, Cristina Rabascio, Maria Teresa Lionetti, Daniele Laszlo, MD, Giovanni Martinelli, MD

Blood (2009) 114 (22): 3754.

https://doi.org/10.1182/blood.V114.22.3754.3754

Published: 2009

Journal Articles

Rituximab and 2-Cda Activity in CLL/SLL Patients: An Update of Pharmacogenomic and Clinical Results

Paola Bertazzoni, Cristina Rabascio, Liliana Calabrese, Federica Gigli, Simona Bassi, MD, Luca Nassi, Simona Sammassimo, Sara Steffanoni, Davide Radice, Angelica Calleri, Emilia Cocorocchio, Daniele Laszlo, Giovanni Martinelli

Blood (2008) 112 (11): 3171.

https://doi.org/10.1182/blood.V112.11.3171.3171

Published: 2008

Journal Articles

Molecular and Functional Analysis of Stem Cell Compartment of Chronic Myelogenous Leukemia Reveals the Presence of a CD34 − cell Population with Intrinsic Resistance to IMATINIB Treatment

Valentina Salvestrini, Rossella Manfredini, MD, Miriam Fogli, Elisa Bianchi, Simona Salati, PhD, Marilina Amabile, Francesco Bertolini, Agostino Tafuri, Roberta Zini, Nicoletta Testoni, Cristina Rabascio, Lara Rossi, Giovanni Martinelli, Michele Baccarani, MD, Sergio Ferrari, Roberto M Lemoli

Blood (2008) 112 (11): 4221.

https://doi.org/10.1182/blood.V112.11.4221.4221

Published: 2008

Journal Articles

IgG Antibodies against Human Cytomegalovirus Late Protein UL94 in the Pathogenesis of Scleroderma-Like Skin Lesions in Chronic Graft Versus Host Disease

Rocco Pastano, Chiara Dell’Agnola, Caterina Bason, Federica Gigli, Cristina Rabascio, Antonio Puccetti, Gianluigi Cetto, Francesco Bertolini, Fedro Alessandro Peccatori, Giovanni Martinelli, Claudio Lunardi

Blood (2008) 112 (11): 1169.

https://doi.org/10.1182/blood.V112.11.1169.1169

Published: 2008

Journal Articles

Evolving First-Line Treatments -from Chemotherapy to Immunotherapy Alone- in 143 Consecutive Follicular Lymphoma Patients Treated in the Last 14 Years at the European Institute of Oncology, Milano

Simona Bassi, MD, Federica Gigli, Cristina Rabascio, Simona Sammassimo, Patrizia Mancuso, Emilia Cocorocchio, Paola Bertazzoni, Daniele Laszlo, Giancarlo Pruneri, Liliana Calabrese, Maria Teresa Lionetti, Anna Vanazzi, MD, Alessandra Alietti, Luca Nassi, Alberto Agazzi, Rocco Pastano, Fedro Alessandro Peccatori, Giovanni Martinelli

Blood (2008) 112 (11): 5016.

https://doi.org/10.1182/blood.V112.11.5016.5016

Published: 2008

Journal Articles

Continuous Immuno-Chemotherapy Followed by High Dose and Autologous Cell Transplantation May Improve the Event-Free-Survival in Mantle Cell Lymphoma Patients. Experience at the European Institute of Oncology in Milan.

Simona Bassi, MD, Alessandra Alietti, MD, Chiara Corsini, DSc, Federica Gigli, MD, Paola Bertazzoni, MD, Cristina Rabascio, DSc, Patrizia Mancuso, DSc, Emilia Cocorocchio, MD, Daniele Laszlo, MD, Giancarlo Pruneri, MD, Lorenzo Preda, MD, Sarah J. Liptrott, BN, Rosaria Cascio, PH, Francesco Bertolini, MD, Giovanni Martinelli, MD

Blood (2007) 110 (11): 5116.

https://doi.org/10.1182/blood.V110.11.5116.5116

Published: 2007

Journal Articles

Expression of the Human Concentrative Nucleotide Transporter (hCNT1) Gene Correlates with Clinical Response in Patients Affected by Waldenstrom’s Macroglobulinemia (WM), Undergoing a Combination Treatment with Cladribine (2-CdA) and Rituximab.

Daniele Laszlo, MD, Cristina Rabascio, DSc, Giovanna Andreola, MD, Luca Saronni, DSc, Liliana Calabrese, DSc, Luigi Rigacci, MD, Alberto Fabbri, MD, Antonello Pinto, MD, Ferdinando Frigeri, MD, Atto Billio, MD, Graziella Pinotti, MD, Simona Sammassimo, MD, Giovanni Martinelli, MD

Blood (2007) 110 (11): 1357.

https://doi.org/10.1182/blood.V110.11.1357.1357

Published: 2007

Journal Articles

Angio-Phenotype of Pediatric Acute Lymphoblastic Leukemia and Pharmacodynamic Evaluation of the Antiangiogenic Activity of Corticosteroids.

Sylvain Baruchel, Patricia Mancuso, Marco Marinoni, Valentina Raia, Cristina Rabascio, Angelica Calleri, Luca Saronni, Diana Stempak, Jessica Quarna, Pierluigi Antoiotti, Andrea Biondi, Francesco Bertolini, Alessandra Sala

Blood (2006) 108 (11): 4466.

https://doi.org/10.1182/blood.V108.11.4466.4466

Published: 2006

Journal Articles

Comparison of Three Different NOD/SCID-Related Strains in Preclinical Models of Acute Leukemia.

Alice Agliano, Ines Martin-Padura, Paola Merighetti, Patrizia Mancuso, Cristina Rabascio, Leonard D. Shultz, Francesco Bertolini

Blood (2006) 108 (11): 2361.

https://doi.org/10.1182/blood.V108.11.2361.2361

Published: 2006

Journal Articles

High Dose Chemotherapy with Autologous Stem Cell Support Is Effective in Resistant and Refractory Hodgkin Lymphoma. A Single Center Analysis.

Emilia Cocorocchio, MD, Fedro Peccatori, MD, Simona Bassi, MD, Federica Gigli, MD, Davide Radice, Giancarlo Pruneri, MD, Cristina Rabascio, Liliana Calabrese, Giovanni Martinelli, MD

Blood (2005) 106 (11): 5506.

https://doi.org/10.1182/blood.V106.11.5506.5506

Published: 2005

Journal Articles

Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation in Renal Cell Carcinoma: The EIO Experience.

Rocco Pastano, MD, Daniele Laszlo, MD, Giovanna Andreola, MD, Federica Gigli, MD, Cristina Rabascio, Valentina Raia, Manuela Cazzanti, Fedro Peccatori, MD, Giovanni Martinelli, MD

Blood (2005) 106 (11): 5424.

https://doi.org/10.1182/blood.V106.11.5424.5424

Published: 2005

Journal Articles

Tumor Control Achieved Despite Loss of Chimaerism in Renal Cell Carcinoma (RCC) Following Non-Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT): A Case Report.

Giovanna Andreola, MD, Federica Gigli, MD, Cristina Rabascio, Manuela Cazzanti, Fedro Peccatori, MD, Saverio Cinieri, MD, Rocco Pastano, MD, Giovanni Martinelli, MD

Blood (2005) 106 (11): 5401.

https://doi.org/10.1182/blood.V106.11.5401.5401

Published: 2005

Journal Articles

Prognostic Value of BCL2 Determination in Follicular NHL Patients Treated with Alkylating Containing Regimen Alone or in Combination with Rituximab.

Daniele Laszlo, Cristina Rabascio, Giovanna Andreola, Chiara Corsini, Fedro Peccatori, Anna Vanazzi, Rosaria Balzano, Francesco Bertolini, Giovanni Martinelli

Blood (2004) 104 (11): 4629.

https://doi.org/10.1182/blood.V104.11.4629.4629

Published: 2004

Journal Articles

Lymphoma Cell Detection and Follow-Up in the Rituximab Era: Concordance between Flow Cytometry, Qualitative/Quantitative PCR and FISH in the Marrow and Blood from 647 Patients.

Patrizia Mancuso, Elisabetta Muratori, Cristina Rabascio, Angelica Calleri, Chiara Corsini, Francesco Bertolini

Blood (2004) 104 (11): 1376.

https://doi.org/10.1182/blood.V104.11.1376.1376

Published: 2004

NARROW

The More Effective and the More (bio) Similar: Plerixafor and Filgrastim XM02 (tevagastrim) As First Line PBSC Mobilization Strategy in Patients with Multiple Myeloma and Lymphomas Candidate to ABMT

Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34 − cell population with intrinsic resistance to imatinib

Rituximab Reduces Anti-UL94 and Anti-NAG-2 Antibodies Titer and Is Effective against Skin-Chronic Graft Versus Host Disease Resembling Scleroderma.

90 y-Ibritumomab Tiuxetan or Purine Analogues Severely Affect Peripheral Blood Stem Cell Mobilization: An Analysis On 248 Patients.

Rituximab and Chlorambucil as Front-Line Treatment in Untreated Follicular Lymphoma: a Combination with a Durable Response and Low Toxicity Profile.

Rituximab and 2-Cda Activity in CLL/SLL Patients: An Update of Pharmacogenomic and Clinical Results

Molecular and Functional Analysis of Stem Cell Compartment of Chronic Myelogenous Leukemia Reveals the Presence of a CD34 − cell Population with Intrinsic Resistance to IMATINIB Treatment

IgG Antibodies against Human Cytomegalovirus Late Protein UL94 in the Pathogenesis of Scleroderma-Like Skin Lesions in Chronic Graft Versus Host Disease

Evolving First-Line Treatments -from Chemotherapy to Immunotherapy Alone- in 143 Consecutive Follicular Lymphoma Patients Treated in the Last 14 Years at the European Institute of Oncology, Milano

Continuous Immuno-Chemotherapy Followed by High Dose and Autologous Cell Transplantation May Improve the Event-Free-Survival in Mantle Cell Lymphoma Patients. Experience at the European Institute of Oncology in Milan.

Expression of the Human Concentrative Nucleotide Transporter (hCNT1) Gene Correlates with Clinical Response in Patients Affected by Waldenstrom’s Macroglobulinemia (WM), Undergoing a Combination Treatment with Cladribine (2-CdA) and Rituximab.

Angio-Phenotype of Pediatric Acute Lymphoblastic Leukemia and Pharmacodynamic Evaluation of the Antiangiogenic Activity of Corticosteroids.

Comparison of Three Different NOD/SCID-Related Strains in Preclinical Models of Acute Leukemia.

High Dose Chemotherapy with Autologous Stem Cell Support Is Effective in Resistant and Refractory Hodgkin Lymphoma. A Single Center Analysis.

Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation in Renal Cell Carcinoma: The EIO Experience.

Tumor Control Achieved Despite Loss of Chimaerism in Renal Cell Carcinoma (RCC) Following Non-Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT): A Case Report.

Prognostic Value of BCL2 Determination in Follicular NHL Patients Treated with Alkylating Containing Regimen Alone or in Combination with Rituximab.

Lymphoma Cell Detection and Follow-Up in the Rituximab Era: Concordance between Flow Cytometry, Qualitative/Quantitative PCR and FISH in the Marrow and Blood from 647 Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only